Cargando…
519. Immune responses and COVID-19 severity
BACKGROUND: The coronavirus-19-disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to >200 countries and surpassed 7 million cases. There is a broad range of COVID-19 illness, ranging from milder disease to a rapidly progressive respir...
Autores principales: | salvatore, mirella, Vorkas, Charles K, Sing, Harjot, Morales, Ayana, Soave, Rosemary, Kapatia, Shashi, Ellsworth, Grant, Saito, Kotha, Brown, Christopher D, Hsu, Jing-Mei, Casano, Joseph, Inghirami, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776417/ http://dx.doi.org/10.1093/ofid/ofaa439.713 |
Ejemplares similares
-
Longitudinal immune profiling of mild and severe COVID-19 reveals
innate and adaptive immune dysfunction and provides an early prediction tool for
clinical progression
por: Rendeiro, André F., et al.
Publicado: (2020) -
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression
por: Rendeiro, André F, et al.
Publicado: (2020) -
Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment
por: Rendeiro, André F., et al.
Publicado: (2022) -
SUN-519 Hypokalemic Periodic Paralysis
por: Godfrey, Sean, et al.
Publicado: (2020) -
P519: RISK STRATIFICATION BY NOMOGRAM SCORING SYSTEM OF NPM1-MUTATED CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIALEUKAEMIA BASED ON A MULTI-GENE PANEL
por: Zhao, Mingyue, et al.
Publicado: (2023)